Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population

BACKGROUND Decreased maternal folate levels are associated with having a child with a neural tube defect (NTD), and periconceptual folic acid supplementation reduces this risk by >50%. Vitamin B12 (as methylcobalamin) is a cofactor for methionine synthase, an enzyme that plays a key role in folat...

Full description

Saved in:
Bibliographic Details
Published in:Birth defects research. A Clinical and molecular teratology Vol. 73; no. 4; pp. 239 - 244
Main Authors: Swanson, Deborah A., Pangilinan, Faith, Mills, James L., Kirke, Peadar N., Conley, Mary, Weiler, Andrea, Frey, Tiffany, Parle-McDermott, Anne, O'Leary, Valerie B., Seltzer, Rebecca R., Moynihan, Kathryn A., Molloy, Anne M., Burke, Helen, Scott, John M., Brody, Lawrence C.
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-04-2005
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Decreased maternal folate levels are associated with having a child with a neural tube defect (NTD), and periconceptual folic acid supplementation reduces this risk by >50%. Vitamin B12 (as methylcobalamin) is a cofactor for methionine synthase, an enzyme that plays a key role in folate metabolism. Alterations in vitamin B12 metabolism may influence the development of NTDs. Low levels of maternal plasma vitamin B12 and reduced binding of vitamin B12 by transcobalamin II (TCII) are independent risk factors for NTDs. TCII levels are altered in the amniotic fluid of pregnancies affected by NTDs. Given this evidence, inherited variants in genes involved in vitamin B12 trafficking such as TCII are candidate NTD risk factors. METHODS We used case/control and family‐based association methods to investigate whether six common polymorphisms in the TCII gene influence NTD risk. TCII genotypes were determined for more than 300 Irish NTD families and a comparable number of Irish controls. RESULTS Allele and genotype frequencies for each polymorphism did not differ between family members and controls. CONCLUSIONS These six TCII polymorphisms do not strongly influence NTD risk in the Irish population. The Supplementary Material for this article can be found on the Birth Defects Research (Part A) website http://www.mrw.interscience.wiley.com/suppmat/1542‐0752/suppmat/2005/73/v73.4.swanson.html Birth Defects Research (Part A), 2005. Published 2005 Wiley‐Liss, Inc.
Bibliography:Pharmacology Research Associate Fellowship from the National Institute of General Medical Sciences
A Microsoft Word document that contains Supplementary Table S1: "Odds ratios and 95% confidence intervals calculated by comparing candidate homozygous TCII genotypes in NTD family groups vs. controls".
This article is a US government work and, as such, is in the public domain in the United States of America.
This article was prepared by a group consisting of both United States government employees and non-United States government employees, and as such is subject to 17 U.S.C. Sec. 105.
istex:8828C8CE8E5A8281455401B4F451CBFFD5483311
ark:/67375/WNG-X212KNRQ-P
Health Research Board
ArticleID:BDRA20122
National Institutes of Health
National Human Genome Research Institute
National Institute of Child Health and Human Development
All authors are members of the Birth Defects Research Group.
This article was prepared by a group consisting of both United States government employees and non‐United States government employees, and as such is subject to 17 U.S.C. Sec. 105.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1542-0752
1542-0760
DOI:10.1002/bdra.20122